



















The German capital region is one of the leading life sciences and healthcare industries centers in the world. A total of around 30,000 employees work in more than 500 companies in the pharma, the biotech and the medtech industry.













Effective 30 of September 2017, Peter Greven Group, a manufacturer of oleochemical derivatives, has formed Norac Additives and acquired the assets of the additives division of US company Norac.